Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome

NCT01160770 is registered in ClinicalTrials.gov with Lundbeck LLC as lead sponsor.

NCT NCT01160770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
Lead sponsor
Lundbeck LLC
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
February 29, 2012
Enrollment
267 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lennox-gastaut syndrome